Eagle Asset Management Inc. purchased a new stake in Healthways Inc. (NASDAQ:HWAY) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 586,947 shares of the company’s stock, valued at approximately $15,530,000. Eagle Asset Management Inc. owned 1.60% of Healthways as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the company. Acrospire Investment Management LLC increased its position in Healthways by 80.9% in the second quarter. Acrospire Investment Management LLC now owns 9,612 shares of the company’s stock valued at $111,000 after buying an additional 4,300 shares during the period. Quantitative Systematic Strategies LLC acquired a new position in Healthways during the second quarter valued at approximately $118,000. Profund Advisors LLC increased its position in shares of Healthways by 4.5% in the second quarter. Profund Advisors LLC now owns 10,668 shares of the company’s stock worth $123,000 after buying an additional 456 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its position in shares of Healthways by 7.6% in the second quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 11,685 shares of the company’s stock worth $135,000 after buying an additional 825 shares during the last quarter. Finally, KBC Group NV purchased a new position in shares of Healthways during the second quarter worth approximately $147,000. Institutional investors and hedge funds own 94.03% of the company’s stock.

Institutional Ownership by Quarter for Healthways (NASDAQ:HWAY)

Shares of Healthways Inc. (NASDAQ:HWAY) traded up 1.94% during midday trading on Wednesday, reaching $23.60. 235,336 shares of the company were exchanged. The stock’s 50-day moving average price is $23.60 and its 200-day moving average price is $19.25. Healthways Inc. has a 52-week low of $9.18 and a 52-week high of $27.30. The company’s market capitalization is $912.92 million.

Healthways (NASDAQ:HWAY) last issued its earnings results on Tuesday, November 1st. The company reported $0.30 EPS for the quarter, missing the Zacks’ consensus estimate of $0.52 by $0.22. Healthways had a negative net margin of 24.50% and a positive return on equity of 13.49%. The business earned $125 million during the quarter, compared to analysts’ expectations of $124.71 million. During the same period in the prior year, the business posted $0.35 EPS. The business’s revenue was up 10.1% on a year-over-year basis. Analysts anticipate that Healthways Inc. will post $1.64 EPS for the current year.

WARNING: “Eagle Asset Management Inc. Invests $15,530,000 in Healthways Inc. (HWAY)” was published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another site, it was stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2016/11/30/eagle-asset-management-inc-invests-15530000-in-healthways-inc-hway.html.

A number of equities analysts recently commented on the stock. Zacks Investment Research downgraded shares of Healthways from a “buy” rating to a “hold” rating in a research note on Tuesday, September 20th. FBR & Co boosted their target price on shares of Healthways from $16.00 to $21.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 10th. Barrington Research reiterated an “outperform” rating and set a $30.00 target price (up previously from $29.00) on shares of Healthways in a research note on Thursday, October 13th. Barclays PLC upgraded shares of Healthways from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $12.00 to $27.00 in a research note on Monday, August 22nd. Finally, Oppenheimer Holdings Inc. upgraded shares of Healthways to an “outperform” rating and set a $27.00 target price for the company in a research note on Sunday, August 14th. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company’s stock. Healthways presently has a consensus rating of “Hold” and an average target price of $25.64.

In related news, Director Mary Jane England sold 3,600 shares of the firm’s stock in a transaction on Friday, November 18th. The shares were sold at an average price of $22.26, for a total transaction of $80,136.00. Following the completion of the sale, the director now directly owns 30,871 shares of the company’s stock, valued at approximately $687,188.46. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Robert J. Greczyn, Jr. purchased 5,000 shares of the stock in a transaction that occurred on Friday, November 4th. The shares were purchased at an average cost of $19.55 per share, with a total value of $97,750.00. Following the completion of the acquisition, the director now owns 30,578 shares in the company, valued at approximately $597,799.90. The disclosure for this purchase can be found here. 14.01% of the stock is currently owned by insiders.

Healthways Company Profile

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

5 Day Chart for NASDAQ:HWAY

Receive News & Stock Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related stocks with our FREE daily email newsletter.